Veröffentlichungen

Expression of activating transcription factor 5 (ATF5) is increased in astrocytomas of different WHO grades and correlates with survival of glioblastoma patients

J. Feldheim
A.F. Kessler
D. Schmitt
L. Wilczek
T. Linsenmann
M. Dahlmann
C.M. Monoranu
R.I. Ernestus
C. Hagemann
M. Löhr

MACC1 - the first decade of a key metastasis molecule from gene discovery to clinical translation

H. Radhakrishnan
W. Walther
F. Zincke
D. Kobelt
F. Imbastari
M. Erdem
B. Kortüm
M. Dahlmann
U. Stein

Oncogenic MYD88 mutations in lymphoma: novel insights and therapeutic possibilities

A.N.R. Weber
Y. Cardona Gloria
Ö. Çınar
H.C. Reinhardt
A. Pezzutto
O.O. Wolz

FACT sets a barrier for cell fate reprogramming in Caenorhabditis elegans and human cells

E. Kolundzic
A. Ofenbauer
S.I. Bulut
B. Uyar
G. Baytek
A. Sommermeier
S. Seelk
M. He
A. Hirsekorn
D. Vucicevic
A. Akalin
S. Diecke
S.A. Lacadie
B. Tursun

01. August 2018 in Br J Haematol

Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B-cell non-Hodgkin lymphoma

N.H. Dang
M. Ogura
S. Castaigne
L.E. Fayad
M. Jerkeman
J. Radford
A. Pezzutto
I. Bondarenko
D.A. Stewart
M. Shnaidman
S. Sullivan
E. Vandendries
K. Tobinai
R. Ramchandren
P.A. Hamlin
E. Giné
K. Ando

Confocal endomicroscopy in diagnosis of intestinal chronic graft-versus-host disease

K. Rieger
U. Günther
U. Erben
A. Kühl
C. Loddenkemper
A. Pezzutto
B. Siegmund
C. Bojarski